跳至主要内容
临床试验/NCT06250491
NCT06250491招募中不适用

Effects of Deep rTMS in Neuropathic Pain or Fibromyalgia : a Bicenter Randomized Sham Controlled Study

Nadine ATTAL4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
4
主要终点
Effects of rTMS versus sham rTMS on pain relief at 13 weeks

研究概览

简要总结

This study will investigate the efficacy and safety of "deep" rTMS on neuropathic pain or fibromyalgia. It will be randomized and sham controlled and will last 3 months. Patients will be randomized to receive acctive rTMS or sham rTMS and will receive repeated rTMS sessions (5 daily sessions then one session per week then every 2 to 3 weeks for up to 10 weeks).

详细描述

This double blind sham controlled parallel group bicenter study will assess the efficacy and safety of repeated sessions of deep rTMS using H coil in patients with neuropathic pain or fibromyalgia. Primary outcome will be % of pain relief at week 13.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic pain ≥ 6 months, at least 4/10 on a 0-10 NRS, present every day or nearly every day
  • Neuropathic pain (confirmed with Douleur Neuropathique en 4 questions and international criteria from NeuPSIG) or fibromyalgia (revised ACR criteria)
  • Stable concomitant medications for pain for at least one month
  • Able to fill out questionnaires and understand and speak French

排除标准

  • Contraindications to rTMS
  • Prior treatment with rTMS
  • Progressive severe condition (eg cancer)
  • Psychosis
  • Psychoactive drug abuse

结局指标

主要结局

Effects of rTMS versus sham rTMS on pain relief at 13 weeks

时间窗: 13 weeks

Pain relief scale from the Brief Pain Inventory rated from 0 to 100 %

次要结局

  • Self-reported pain intensity(Baseline then every day at the same time of day (morning or evening))
  • Effects of rTMS vs sham on pain right now from Brief Pain Inventory(Baseline then each follow up visit at the pain center for up to 13 weeks)
  • Effects of rTMS vs sham on average pain intensity(Each follow up visit at the pain center for up to 13 weeks)
  • Effects of rTMS vs sham on sleep(Baseline then each follow up visit at the pain center for up to 13 weeks)
  • Comparison of the efficacy of rTMS on the primary outcome between patients with neuropathic pain and fibromyalgia(Week 13)
  • Effects of rTMS vs sham on pain as its least from Brief Pain Inventory(Baseline then each follow up visit at the pain center for up to 13 weeks)
  • Blinding assessment(13 weeks)
  • Patient global impression of change(13 weeks)
  • Effects of rTMS versus sham on anxiety and depressive symptoms(Baseline then each follow up visit at the pain center for up to 13 weeks)
  • Effects on Global Impression of change assessed by the clinician(13 weeks (end of the treatment))
  • Effects of rTMS vs sham on pain interference(Baseline then each follow up visit at the pain center for up to 13 weeks)
  • Effects of rTMS vs sham on quality of life(Baseline then each follow up vist at the pain center for up to 13 weeks)
  • Side effects of rTMS or sham(Each follow up visit at the pain center for up to 13 weeks)
  • Effects of rTMS vs sham on pain as its worst from Brief Pain Inventory(Baseline then each follow up visit at the pain center for up to 13 weeks)

研究者

发起方
Nadine ATTAL
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nadine ATTAL

Clinical Professor

Hospital Ambroise Paré Paris

研究点 (4)

Loading locations...

相似试验

Deep rTMS (H-coil) for Neuropathic Pain or... | 临床试验